Merit Medical Acquires View Point to Expand Oncology Devices
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Bispecific Antibody cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Neurodegenerative Disease Oncology oncology innovation Ophthalmology Orphan Drug orphan drug designation Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SOUTH JORDAN, Utah, April 1, 2026 Merit Medical Systems, Inc. has announced the acquisition of View Point Medical, Inc....
March 09, 2026 — New York, London, and São Paulo A major advancement in nuclear medicine imaging technology has...
SECAUCUS, N.J., March 2, 2026 Quest Diagnostics (NYSE: DGX) has introduced Quest AI Companion, an AI-powered chat feature integrated...
Raleigh, N.C. | January 28, 2026 — Lumexa Imaging, one of the largest U.S. providers of outpatient diagnostic imaging...
VANCOUVER, BC — December 5, 2025 — TempraMed Technologies Ltd. announced a major expansion into Western Europe through a...
SOUTH ORANGE, N.J., November 6, 2025 — Nephros, Inc. (Nasdaq: NEPH), a leader in water filtration solutions for the...
Durham, N.C., September 25, 2025 – HemoSonics LLC, a medical device innovator in acute bleeding management, has received 510(k)...
STAMFORD, CT, September 25, 2025 — Apiject Systems, Corp., a leading medical technology innovator, submitted its New Drug Application...
